{"id":"ar1001","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital yeast infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the SGLT2 receptor, AR1001 reduces glucose reabsorption in the kidneys, leading to decreased blood glucose levels. This mechanism is particularly effective in treating type 2 diabetes.","oneSentence":"AR1001 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:33.986Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT05531526","phase":"PHASE3","title":"Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AriBio Co., Ltd.","startDate":"2022-12-23","conditions":"Alzheimer Disease","enrollment":1535},{"nctId":"NCT03625622","phase":"PHASE2","title":"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease","status":"COMPLETED","sponsor":"AriBio Co., Ltd.","startDate":"2019-04-01","conditions":"Mild to Moderate Alzheimer's Disease","enrollment":210}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AR1001","genericName":"AR1001","companyName":"AriBio Co., Ltd.","companyId":"aribio-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AR1001 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}